SBI Securities’s Starling Oncology STLN Stock Holding History

SBI Securities’s Portfolio STLN Stock Details STLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.55K	Sell	1,195 -405	-25%	-$2.42K	﹤0.01%	2011
2026 Q2	$8.69K	Buy	+1,600	New	+$6.72K	﹤0.01%	1910
2026 Q1	–	Sell	-3,500	Closed	-$12.5K	–	4154
2025 Q4	$12.5K	Hold	3,500	–	–	﹤0.01%	1627
2025 Q3	$12.2K	Buy	3,500 +500	+17%	+$1.71K	﹤0.01%	1679
2025 Q2	$6.15K	Buy	3,000 +2,800	+1,400%	+$7K	﹤0.01%	1890
2025 Q1	$228	Buy	+200	New	+$155	﹤0.01%	3177

Other funds holding STLN

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Kingswood Wealth Advisors San Diego, California $2.6B AUM 27.46% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

T3 Companies New York $103M AUM 54.73% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Berkshire Money Management Dalton, Massachusetts $1.16B AUM 13.8% 1-Year Est. Return

Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return

Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 25.53% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

SBI Securities's STLN Position: Q3 2026 in Review

SBI Securities reduced its Starling Oncology (STLN) stake by 25% in Q3 2026, selling an estimated $2.42K and leaving 1,195 shares worth $7.55K. The position accounts for ﹤0.01% of the portfolio, ranked #2011.

SBI Securities first reported a position in STLN in Q1 2025 and has held it in 6 quarters since. The position peaked at $12.5K in Q4 2025. 25 funds tracked by Wall St. Rank hold STLN as of Q3 2026.

SBI Securities held 1,195 shares of Starling Oncology worth $7.55K as of Q3 2026.
SBI Securities sold 405 Starling Oncology shares in Q3 2026, an estimated $2.42K.
Starling Oncology made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2011 holding.
SBI Securities first reported a position in Starling Oncology in Q1 2025 and has held it in 6 quarters since.
SBI Securities's Starling Oncology position peaked at $12.5K in Q4 2025.
25 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.